Establishment and characterization of a cell line (DEOC-1) originating from a human malignant melanoma of the skin

被引:3
作者
Maeshima, Seiji [1 ]
Yamada, Takashi [1 ]
Kiyokanei, Kimihiro [2 ]
Mori, Hiroshi [1 ]
机构
[1] Osaka Med Coll, Dept Pathol, Takatsuki, Osaka 5698686, Japan
[2] Osaka Med Coll, Dept Dermatol, Takatsuki, Osaka 5698686, Japan
来源
HUMAN CELL | 2007年 / 20卷 / 02期
关键词
cell line; human; malignant melanoma; multidrug resistance-related gene; 5-S-cysteinyldopa; UVEAL-MELANOMA; PHARMACOKINETICS; BIOAVAILABILITY; EXPRESSION; GROWTH;
D O I
10.1111/j.1749-0774.2007.00028.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A new human malignant melanoma cell line, designated DEOC-1, was established from the heel lesion of a 59-year-old man. This cell line has grown well for 84 months. The monolayer, cultured cells are polygonal in shape, appear to be spindle-shaped cells or multipolar cells, and have a tendency to pile up without contact inhibition. The cells are aneuploid, and the modal chromosomal number is in the hyper-triploid range. The cells were transplanted into the subcutis of SCID mice and produced tumors resembling the original tumor. The DEOC-1 cells (1 x 10(6)/5 mL) produced 5-S-cysteinyldopa (5-S-CD). The cells were not sensitive in vitro to any anticancer drug currently used for the treatment of malignant melanoma. Increases in both the protein and the transcriptional levels (mRNA) of multidrug resistance-related genes (multidrug resistance gene 1, multidrug resistance-associated protein I and lung resistance-related protein) were observed in DEOC-I cells. The DEOC-1 cells are well characterized and are a very useful material for basic research of malignant melanoma.
引用
收藏
页码:23 / 38
页数:16
相关论文
共 40 条
[1]  
ALBERT DM, 1984, INVEST OPHTH VIS SCI, V25, P1284
[2]  
BENJAMIN RS, 1974, CANCER CHEMOTH REP 1, V58, P271
[3]   PHARMACOKINETICS OF DACARBAZINE (DTIC) AND ITS METABOLITE 5-AMINOIMIDAZOLE-4-CARBOXAMIDE (AIC) FOLLOWING DIFFERENT DOSE SCHEDULES [J].
BREITHAUPT, H ;
DAMMANN, A ;
AIGNER, K .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (02) :103-109
[4]  
CAMPBELL MA, 1985, CANCER TREAT REP, V69, P833
[5]   AN IMPROVED METHOD FOR THE ESTABLISHMENT OF CELL-LINES FROM PRIMARY SKIN MELANOMAS [J].
CAREY, WD ;
PRUNIERAS, M .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 110 (03) :265-271
[6]   Establishment and characterization of an oral melanoma cell line (ME) [J].
Chang, KW ;
Lin, SC ;
Chao, SY ;
Kwan, PC ;
Chiu, CP ;
Wong, YK .
ORAL ONCOLOGY, 2001, 37 (03) :301-307
[7]   ESTABLISHMENT AND CHARACTERIZATION OF AN UVEAL-MELANOMA CELL-LINE [J].
DEWAARDSIEBINGA, I ;
BLOM, DJR ;
GRIFFIOEN, M ;
SCHRIER, PI ;
HOOGENDOORN, E ;
BEVERSTOCK, G ;
DANEN, EHJ ;
JAGER, MJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (02) :155-161
[8]   Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived) [J].
Diebold, Y ;
Blanco, G ;
Saornil, MA ;
Fernandez, N ;
Lazaro, MC .
CURRENT EYE RESEARCH, 1997, 16 (05) :487-495
[9]  
ELFERINK F, 1987, CANCER TREAT REP, V71, P1231
[10]  
Enjoji M, 1995, Hum Cell, V8, P115